Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 March 2020

What does the bursary cover?

• Accommodation
• Transport (up to 40 km from institution) 
• Meal allowance (including incidental allowance)
• Book allowance 
• Registration
• Tuition
• Funded students with disabilities need to submit claims for assistive devices and human support directly to the university’s Centre for Universal Access and Disability Support (CUADS)/Financial Aid office.

Who qualifies for NSFAS allowances?

STUDENTS STAYING IN A RESIDENCE:
• Books up to a maximum of R5 200
• Actual accommodation cost
• Meals (including incidental allowance) up to a maximum of R15 000
 
STUDENTS LIVING OFF CAMPUS IN FAMILY ACCOMMODATION

• Books up to a maximum of R5 200
• Meals (including incidental allowance) up to a maximum of R15 000
• Transport up to a maximum of R7 500

STUDENTS LIVING OFF CAMPUS IN ACCREDITED and NON-ACCREDITED ACCOMMODATION: 

• Books up to a maximum of R5 200
• Private accommodation amount to a maximum of R34 400
• Meals (including incidental allowance) up to a maximum of R15 000

DISTANCE-LEARNING STUDENTS:

• Books based on the number of modules registered, up to a maximum of R5 200

Please note that students who were registered for the first time at a tertiary institution before 2018 are subject to a maximum NSFAS amount for the year.  The maximum NSFAS amount for 2020 is R93 400.
According to NSFAS policy, payments must be made in the following order of priority if your qualifying NSFAS costs exceed the maximum amount:
1.  Tuition
2.  Books
3.  Accommodation
4.  Meals
5.  Transport
This means that the amount by which you exceeded the maximum NSFAS amount must be deducted from your allowances, starting with the transport and meal allowances.  Therefore, you might not receive the full allowances.

How will NSFAS allowances be paid?

NSFAS allowances will be paid in cash to the student via the Fundi system.  Once the allowances are debited to your student class-fee account, you will receive an SMS message from Fundi to upload your banking details.  Fundi will confirm your banking details and payment will follow.

Please note that no payments will be made to a third party.
You only need to upload your banking details once.  If you experience any problems with uploading your banking details, please contact Fundi at 086 055 5544.


When will I receive my NSFAS allowances?

NSFAS allowances will be paid during the first week of each month over a period of 10 months.  Please note that due to several variables, a specific date for payment cannot be provided.

How do I apply for NSFAS private accommodation?

Please visit the UFS website for a complete guide:
Students
Financial Aid

When will I receive my private accommodation payment?

You must apply online for your private accommodation.  It is compulsory to upload your rental agreement and proof of home address.  If your private accommodation application is approved by the 25th of a month, you will receive payment from your move-in date up to date during the first week of the following month, and thereafter you will receive your monthly payments until November.

How will I know if my private accommodation application status has changed?

You will immediately receive an email on your ufs4life email address when your status changes.  

What should I do if my private accommodation application is incomplete?

Please log in on your Student Self-Service.  The reasons for your incomplete application will be listed under your private accommodation application.  Please correct  the application and resubmit.  Please do not resubmit if the application was not corrected.
Please visit the website for clear explanations on the reasons for incomplete applications if you are unsure of what is expected of you. 

Please note that no payment will be made before your private accommodation application is approved.

When is the closing date for NSFAS private accommodation applications?
The closing date for private accommodation applications is 11 September 2020.  Please note that no extension will be granted.

News Archive

Inaugural lecture: Prof Robert Bragg, Dept. of Microbial, Biochemical and Food Biotechnology
2006-05-17



Attending the inaugural lecture were in front from the left Prof Robert Bragg (lecturer at the Department of Microbial, Biochemical and Food Biotechnology) and Frederick Fourie (Rector and Vice-Chancellor).  At the back from the left were Prof James du Preez (Departmental Chairperson:  Department of Microbial, Biochemical and Food Biotechnology) and Prof Herman van Schalkwyk (Dean: Faculty of Natural and Agricultural Sciences). Photo: Stephen Collett
 

A summary of an inaugural lecture delivered by Prof Robert Bragg at the University of the Free State:

CONTROL OF INFECTIOUS AVIAN DISEASES – LESSONS FOR MAN?

Prof Robert R Bragg
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State

“Many of the lessons learnt in disease control in poultry will have application on human medicine,” said Prof Robert Bragg, lecturer at the University of the Free State’s (UFS) Department of Microbial, Biochemical and Food Biotechnology during his inaugural lecture.

Prof Bragg said the development of vaccines remains the main stay of disease control in humans as well as in avian species.  Disease control can not rely on vaccination alone and other disease-control options must be examined.  

“With the increasing problems of antibiotic resistance, the use of disinfection and bio security are becoming more important,” he said.

“Avian influenza (AI) is an example of a disease which can spread from birds to humans.  Hopefully this virus will not develop human to human transmission,” said Prof Bragg.

According to Prof Bragg, South Africa is not on the migration route of water birds, which are the main transmitters of AI.  “This makes South Africa one of the countries less likely to get the disease,” he said.

If the AI virus does develop human to human transmission, it could make the 1918 flu pandemic pale into insignificance.  During the 1918 flu pandemic, the virus had a mortality rate of only 3%, yet more than 50 million people died.

Although the AI virus has not developed human-to-human transmission, all human cases have been related to direct contact with infected birds. The mortality rate in humans who have contracted this virus is 67%.

“Apart from the obvious fears for the human population, this virus is a very serious poultry pathogen and can cause 100% mortality in poultry populations.  Poultry meat and egg production is the staple protein source in most countries around the world. The virus is currently devastating the poultry industry world-wide,” said Prof Bragg.

Prof Bragg’s research activities on avian diseases started off with the investigation of diseases in poultry.  “The average life cycle of a broiler chicken is 42 days.  After this short time, they are slaughtered.  As a result of the short generation time in poultry, one can observe changes in microbial populations as a result of the use of vaccines, antibiotics and disinfectants,” said Prof Bragg.   

“Much of my research effort has been directed towards the control of infectious coryza in layers, which is caused by the bacterium Avibacterium paragallinarum.  This disease is a type of sinusitis in the layer chickens and can cause a drop in egg product of up to 40%,” said Prof Bragg.

The vaccines used around the world in an attempt to control this disease are all inactivated vaccines. One of the most important points is the selection of the correct strains of the bacterium to use in the vaccine.

Prof Bragg established that in South Africa, there are four different serovars of the bacterium and one of these, the serovar C-3 strain, was believed to be unique to Southern Africa. He also recently discovered this serovar for the first time in Israel, thus indicating that this serovar might have a wider distribution than originally believed.

Vaccines used in this country did not contain this serovar.  Prof Bragg established that the long term use of vaccines not containing the local South African strain resulted in a shift in the population distribution of the pathogen.

Prof Bragg’s research activities also include disease control in parrots and pigeons.   “One of the main research projects in my group is on the disease in parrots caused by the circovirus Beak and Feather Disease virus. This virus causes serious problems in the parrot breeding industry in this country. This virus is also threatening the highly endangered and endemic Cape Parrot,” said Prof Bragg.

Prof Bragg’s research group is currently working on the development of a DNA vaccine which will assist in the control of the disease, not only in the parrot breeding industry, but also to help the highly endangered Cape Parrot in its battle for survival.

“Not all of our research efforts are directed towards infectious coryza or the Beak and Feather Disease virus.  One of my Masters students is currently investigating the cell receptors involved in the binding of Newcastle Disease virus to cancerous cells and normal cells of humans. This work will also eventually lead to a possible treatment of cancer in humans and will assist with the development of a recombinant vaccine for Newcastle disease virus,” said Prof Bragg.

We are also currently investigating an “unknown” virus which causes disease problems in poultry in the Western Cape,” said Prof Bragg.
 
“Although disinfection has been extensively used in the poultry industry, it has only been done at the pre-placement stage. In other words, disinfectants are used before the birds are placed into the house. Once the birds are placed, all use of disinfectants stops,” said Prof Bragg.

“Disinfection and bio security can be seen as the ‘Cinderella’ of disease control in poultry.  This is also true for human medicine. One just has to look at the high numbers of people who die from hospital-acquired infections to realise that disinfection is not a concept which is really clear in human health care,” said Prof Bragg.

Much research has been done in the control of diseases through vaccination and through the use of antibiotics. “These pillars of disease control are, however, starting to crumble and more effort is needed on disinfection and bio security,” said Prof Bragg.

Prof Bragg has been working in close co-operation with a chemical manufacturing company in Stellenbosch to develop a unique disinfectant which his highly effective yet not toxic to the birds.

As a result of this unique product, he has developed the continual disinfection program for use in poultry. In this program the disinfectant is used throughout the production cycle of the birds. It is also used to ensure that there is excellent pre-placement disinfection.

“The program is extensively used for the control of infectious diseases in the parrot-breeding industry in South Africa and the product has been registered in 15 countries around the world with registration in the USA in the final process,” said Prof Bragg.

“Although the problem of plasmid mediated resistance to disinfectants is starting to rear its ugly head, this has allowed for the opening of a new research field which my group will hopefully exploit in the near future,” he said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept